Double helix double take

It's not often that you get to witness a major scientific figure watch his own theatrical indictment.

Written byIshani Ganguli
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It's not often that you get to witness a major scientific figure watch his own theatrical indictment. But at the 2005 annual Sloan Film Summit presented by the Tribeca Film Institute in New York earlier this month, the attendance of Nobel laureate James Watson provides just that opportunity.

The afternoon opened with a panel discussion on "Good Science in Good Films" in which Watson revealed that he had been "upset" by Jeff Goldblum's depiction of him in the 1987 film The Race for the Double Helix. "I thought he was unpleasant," he said. But he quickly conceded that "a friend of mine did say I was unpleasant at the time. You're bound to seem crazy to most people."

Despite this familiarity with unflattering publicity, Watson didn't seem prepared for the final excerpt in a series of readings from upcoming science-based films of a screenplay entitled The Broken Code. Watson himself ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies